Abstract
Background: Among women with unexplained infertility, 28% to 55% of patients with galactorrhea are normoprolactinemic. Bromocriptine, a common treatment for infertile women with hyperprolactinemia, has been used in the treatment of unexplained subfertility in women with galactorrhea and normal prolactin; however, its effectiveness and safety profile have never been determined.
Objective: The aim of this study was to determine the relative effectiveness and safety profile of bromocriptine monotherapy or as an adjunct to clomiphene citrate in women with galactorrhea and normal prolactin levels.
Methods: We conducted a search of the Cochrane Subfertility Review Group specialized register of controlled trials (March 2010), CENTRAL (The Cochrane Library, Issue 3, 2010), MEDLINE (1950–March 2010), EMBASE (1980–March 2010), and the China Biological Medicine Database (inception to March 2010) for relevant randomized controlled trials (RCTs) using the following terms: controlled, randomized, blinded, clinical trials, humans, galactorrhea, prolactin, bromocriptine, infertility, and subfertility. Additionally, reference lists of identified articles were searched for relevant articles.
Results: Of the 8 studies identified, 5 were excluded after full-text review for the following reasons: lack of a placebo group (2); difference in cointerventions (1); difference in end points (1); and systematic review (1). Therefore, 3 RCTs were included in this review. Bromocriptine administered in combination with clomiphene was found to be associated with a higher accumulative pregnancy rate compared with clomiphene monotherapy (fixed odds ratio [OR], 5.33; 95% CI, 2.62–10.88), and a lower miscarriage rate (fixed OR, 0.20; 95% CI, 0.05–0.76). Only 1 trial reported live birth as an outcome, and multiple pregnancy rates were poorly reported. Patient-reported adverse effects were mentioned in the studies, but reports were often incomplete.
Conclusions: This review suggests the effectiveness of bromocriptine with clomiphene for infertility in women with galactorrhea and normal prolactin levels. Further RCTs of adequate power and of high methodologic quality are required to confirm these findings.
Key words: bromocriptine, galactorrhea, infertility, prolactin, randomized controlled trial, meta-analysis
Full Text
The Full Text of this article is available as a PDF (627.2 KB).
References
- 1.Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. 5th ed. Williams & Wilkins; Baltimore, Md: 1994. p. 67. [Google Scholar]
- 2.Hornstein MD, Schust D, Berek JS. Infertility. In: Berek JS, Adashi EY, Hillard PA, editors. Novak's Gynecology. 12th ed. Williams & Wilkins; Baltimore, Md: 1996. pp. 935–940. [Google Scholar]
- 3.National Collaborating Centre for Women's and Children's Health. National Institute for Clinical Excellence . Fertility: Assessment and treatment for people with fertility problems. RCOG Press; 2004. http://www.rcog.org.uk/fdes/rcog-corp/uploaded-files/NEBFertilityFull.pdf Accessed July 15, 2010. [Google Scholar]
- 4.Leung AKC, Pacaud D. Diagnosis and management of galactorrhea. Am Fam Physician. 2004;70:543–550. [PubMed] [Google Scholar]
- 5.Cun YG. Occult hyperprolactinemia and infertility. Foreign Obstet Gynecol. 2002;29:2. [Google Scholar]
- 6.Sauder SE, Frager M, Case GD. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinaemia and amenorrhea: Responses to bromocriptine. J Clin Endocrinol Metab. 1984;59:941–948. doi: 10.1210/jcem-59-5-941. [DOI] [PubMed] [Google Scholar]
- 7.Brown J, Farquhar C, Beck J. Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev. 2009;(4):CD002249. doi: 10.1002/14651858.CD002249.pub4. [DOI] [PubMed] [Google Scholar]
- 8.Kousta E, White DM, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update. 1997;3:359–365. doi: 10.1093/humupd/3.4.359. [DOI] [PubMed] [Google Scholar]
- 9.Eftekhari N. Vol. 1271. 2004. Fertility rate with bromocriptine in infertile women with galactorrhea and normal prolactin level; pp. 22–25. (Int Congr Ser). [Google Scholar]
- 10.Franks S. Use of bromocriptine in hyperprolactinaemic anovulation and related disorders. Drugs. 1979;17:337–348. doi: 10.2165/00003495-197917050-00003. [DOI] [PubMed] [Google Scholar]
- 11.Seibel MM, Oskowitz S, Kamrava M, Taymor ML. Bromocriptine response in normopro-lactinemic patients with polycystic ovary disease: A preliminary report. Obstet Gynecol. 1984;64:213–219. [PubMed] [Google Scholar]
- 12.Padilla SL, Person GK, McDonough PG, Reindollar RH. The efficacy of bromocriptine in patients with ovulatory dysfunction and normoprolactinemic galactorrhea. Fertil Steril. 1985;44:695–698. doi: 10.1016/s0015-0282(16)48989-2. [DOI] [PubMed] [Google Scholar]
- 13.Asukai K, Uemura T, Minaguchi H. Occult hyperprolactinemia in infertile women. Fertil Steril. 1993;60:423–427. doi: 10.1016/s0015-0282(16)56154-8. [DOI] [PubMed] [Google Scholar]
- 14.Jansen R. Overcoming Infertility: A Compassionate Resource for Getting Pregnant. W.H. Freeman and Company; New York, NY: 1997. [Google Scholar]
- 15.Hughes E, Collins J, Vandekerckhove P. Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea. Cochrane Database Syst Rev. 2000;(2):CD000056. doi: 10.1002/14651858.CD000056. [DOI] [PubMed] [Google Scholar]
- 16.Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomised clinical trials: Is blinding necessary? Control Clin Trials. 1996;17:1–12. doi: 10.1016/0197-2456(95)00134-4. [DOI] [PubMed] [Google Scholar]
- 17.Moher D, Pham B, Jones A. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609–613. doi: 10.1016/S0140-6736(98)01085-X. [DOI] [PubMed] [Google Scholar]
- 18.Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2008. http://www.cochrane-handbook.org Version 5.0.0 [updated February 2008]. Accessed July 15, 2010. [Google Scholar]
- 19.Moher D, Cook DJ, Eastwood S. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896–1900. doi: 10.1016/s0140-6736(99)04149-5. [DOI] [PubMed] [Google Scholar]
- 20.DeVane GW, Guzick DS. Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrhea. Fertil Steril. 1986;46:1026–1031. [PubMed] [Google Scholar]
- 21.Parsanezhad ME, Alborzi S, Namavar Jahromi B. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level. Arch Gynecol Obstet. 2004;269:125–129. doi: 10.1007/s00404-002-0437-x. [DOI] [PubMed] [Google Scholar]
- 22.Akhlaghi F, Hamedi A. Investigation on the effects of bromocriptine and dexamethasone in polycystic ovarian disease with clomiphene citrate resistance. Int J Gynecol Obst. 2004;3 [Google Scholar]
- 23.Anzhen Y, Liang Y. Treatment of bromocriptine in the patients with normal prolactin levels for ovulation induction. Chin Comp Clin. 2006;22:275–276. [Google Scholar]
- 24.Haixia W. Clinical observation of treatment in unexplained infertility with bromocriptine. Shandong Chin Med. 2002;42:19. [Google Scholar]
- 25.Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Zheng MH, Bai JL, Meng MB. Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update. Curr Ther Res Clin Exp. 2008;69:288–304. doi: 10.1016/j.curtheres.2008.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]